Pipeline
Etubics
is in Phase I/II Clinical Trials with a therapeutic vaccine
product that is intended to treat Carcinoembryonic Antigen
(CEA)-expressing cancers such as colorectal cancer. Plans are underway
to initiate clinical trials for a therapeutic breast cancer vaccine and
a preventative influenza vaccine. Etubics continues to move forward on
its pre clinical activities for vaccines for HIV, malaria and other
difficult to treat diseases.
